Mayeux R, Honig LS, Tang MX, Manly J, Stern Y, Schupf N, Mehta PD. Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology. 2003 Nov 11;61(9):1185-90. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)		 Cohort
(N)		 Measurement
Mean ± SD		 Method;
Assay Name;
Manufacturer		 Diagnostic
Criteria
Aβ40
(Plasma)		 AD
(79)		 153.6 ± 46.7
pg/mL		 ELISA;
Other/Not Specified;
In-house		 McKhann et al., 1984
Aβ40
(Plasma)		 CTRL-
CNC
(365)		 133.3 ± 61.9
pg/mL		 ELISA;
Other/Not Specified;
In-house
Aβ42
(Plasma)		 AD
(79)		 68.7 ± 24.2
pg/mL		 ELISA;
Other/Not Specified;
In-house		 McKhann et al., 1984
Aβ42
(Plasma)		 CTRL-
CNC
(365)		 58.8 ± 32.9
pg/mL		 ELISA;
Other/Not Specified;
In-house

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. In the Blood: What Can Plasma Aβ Tell Us About Alzheimer’s?
  2. The Value of Biomarkers—Diagnosis and Genetic Screens
  3. Research Brief: New Methods for Aβ Detection, Production
  4. Plasma Aβ Testing Beset by Questions of Assays, Biology, Timing

AlzBiomarker

  1. AD vs CTRL : Aβ40 (Plasma and Serum)
  2. CTRL vs AD : Aβ40 (Plasma and Serum)
  3. AD vs CTRL : Aβ42 (Plasma and Serum)
  4. CTRL vs AD : Aβ42 (Plasma and Serum)